Amy N. Luckenbaugh MD

Assistant Professor
Department of Urology
Division of Urologic Oncology

Medical Degree: State University of New York at Buffalo
Residency: University of Michigan
Fellowship: Vanderbilt University Medical Center
Clinical Interests: Bladder Cancer, Kidney Cancer, Prostate Cancer, Testis Cancer, Urologic Cancer

Dr. Luckenbaugh is a high-volume surgeon whose clinical focus centers around the comprehensive care of patients with urologic malignancies. She currently serves as secretary for the Society of Women in Urology, and through her research aims to mitigate variation in healthcare delivery.

Active Clinical Trials

Taris Biomedical-MIBC

A Multicenter Study Evaluating Safety and Efficacy of TAR-200 in Subjects with Muscle-Invasive Urothelial Carcinoma of The Bladder Who are Ineligible for or Refuse Cisplatin-based Chemotherapy and Who are Unfit for Radical Cystectomy

Learn more about this study

PI: Amy Luckenbaugh, MD

FKD Therapies/Instiladrin

A Phase III, Open Label Study to Evaluate the Safety and Efficacy of INSTILADRIN (rAd-IFN/Syn3) Administered Intravesically to Patients with High Grade, BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

Learn more about this trial

PI: Amy Luckenbaugh, MD

Female Cystectomy

Sexual Function in Women after Radical Cystectomy.

PI: Amy Luckenbaugh, MD